Antibiotic resistance of Helicobacter pylori in Israeli children

Scandinavian Journal of Gastroenterology

Volumn 45, Issue 5, 2010, Pages 550-555

  Zevit, Noam ^a,c   Levy, Itzhak ^a,c   Shmuely, Haim ^b,c   Samra, Zmira ^b,c   Yahav, Jacob ^b,d  

^a SCHNEIDER CHILDREN S MEDICAL CENTER OF ISRAEL   (Israel)

^b RABIN MEDICAL CENTER   (Israel)

^c TEL AVIV UNIVERSITY   (Israel)

^d KAPLAN MEDICAL CENTER   (Israel)

Author keywords

Clarithromycin; Gastritis; Metronidazole; Pediatric

Indexed keywords

AMOXICILLIN; CLARITHROMYCIN; LEVOFLOXACIN; METRONIDAZOLE; TETRACYCLINE;

ADOLESCENT; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL COLONIZATION; CHILD; CONTROLLED STUDY; DRUG USE; EPSILOMETER TEST; FEMALE; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; HUMAN TISSUE; ISRAEL; MAJOR CLINICAL STUDY; MALE; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; STOMACH BIOPSY; TREATMENT FAILURE;

ADOLESCENT; AMOXICILLIN; ANALYSIS OF VARIANCE; ANTI-BACTERIAL AGENTS; BIOPSY; CHI-SQUARE DISTRIBUTION; CHILD; CHILD, PRESCHOOL; CLARITHROMYCIN; DRUG RESISTANCE, MULTIPLE, BACTERIAL; FEMALE; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; INFANT; ISRAEL; MALE; METRONIDAZOLE; MICROBIAL SENSITIVITY TESTS; OFLOXACIN; PROSPECTIVE STUDIES; QUESTIONNAIRES; TETRACYCLINE; TREATMENT FAILURE;

EID: 77951689065     PISSN: 00365521     EISSN: 15027708     Source Type: Journal    
DOI: 10.3109/00365521003663688     Document Type: Article

References (28)

1. Kandulski A, Selgrad M, Malfertheiner P. Helicobacter pylori infection: a clinical overview. Dig Liver Dis 2008;40:619-626
2. Malfertheiner P, Megraud F, O'Morain C, Bazzoli F, El-Omar E, Graham D, et al. Current concepts in the management of Helicobacter pylori infection: the Maastricht III Consensus Report. Gut 2007;56:772-781 (Pubitemid 46854190)
3. Bourke B, Ceponis P, Chiba N, Czinn S, Ferraro R, Fischbach L, et al. Canadian Helicobacter Study Group Consensus Conference: update on the approach to Helico-bacter pylori infection in children and adolescents-an evidence-based evaluation. Can J Gastroenterol 2005;19: 399-408.
4. Chey WD, Wong BC. American College of Gastroenterology guideline on the management of Helicobacter pylori infection. Am J Gastroenterol 2007;102:1808-1825 (Pubitemid 47206706)
5. Tetracycline Hydrochloride; Barr Laboratories, Inc. FDA-approved label, Monograph, 2006. Available at: http://dailymed.nlm.nih.gov/dailymed/getFile.cfm? id=577&type= pdf&name=1742c476-e7dd-4bc5-bf4b-9935612a96c9 (last accessed on 22.06.2009).
6. Levaquin (levofloxacin). FDA Approved Medication Label, section 17.5, 2008. Available at: http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?id=8574 (last accessed on 22.06.2009).
7. Oderda G, Shcherbakov P, Bontems P, Urruzuno P, Romano C, Gottrand F, et al. Results from the pediatric European register for treatment of Helicobacter pylori (PERTH). Helicobacter 2007;12:150-156 (Pubitemid 46272569)
8. Hoffman PS. Antibiotic resistance mechanisms of Helico-bacter pylori. Can J Gastroenterol 1999;13:243-249 (Pubitemid 29221774)
9. Koletzko S, Richy F, Bontems P, Crone J, Kalach N, Monteiro ML, et al. Prospective multicentre study on antibiotic resistance of Helicobacter pylori strains obtained from children living in Europe. Gut 2006;55:171116.
10. Kalach N, Serhal L, Asmar E, Campeotto F, Bergeret M, Dehecg E, et al. Helicobacter pylori primary resistant strains over 11 years in French children. Diagn Microbiol Infect Dis 2007;59:217-222 (Pubitemid 47484134)
11. Tolia V, Brown W, El-Baba M, Lin CH. Helicobacter pylori culture and antimicrobial susceptibility from pediatric patients in Michigan. Pediatr Infect Dis J 2000;19:1167-1171 (Pubitemid 32003361)
12. Graham DY. Antibiotic resistance in Helicobacter pylori: implications for therapy. Gastroenterology 1998;115: 1272-1277 (Pubitemid 28485620)
13. Malfertheiner P, Megraud F, O'Morain C, Hungin AP, Jones R, Axon A, et al. Current concepts in the management of Helicobacter pylori infection-the Maastricht 2-2000 Consensus Report. Aliment Pharmacol Ther 2002;16:167-180 (Pubitemid 34146357)
14. Faber J, Bar-Meir M, Rudensky B, Schlesinger Y, Rachman E, Benenson S, et al. Treatment regimens for Helicobacter pylori infection in children: is in vitro susceptibility testing helpful? J Pediatr Gastroenterol Nutr 2005;40:571-574 (Pubitemid 40617184)
15. Samra Z, Shmuely H, Niv Y, Dinari G, Passaro DJ, Geler A, et al. Resistance of Helicobacter pylori isolated in Israel to metronidazole, clarithromycin, tetracycline, amoxicillin and cefixime. J Antimicrob Chemother 2002;49:1023-1026 (Pubitemid 34692899)
16. Avidan B, Weiss B, Chowers Y, Younash A, Bar-Meir S, Keller N. Sensitivity and resistance of Helicobacter pylori to antibiotic treatment. Harefuah 1999;137:272-274
17. Yahav J, Samra Z, Niv Y, Evans CT, Passaro DJ, Dinari G, et al. Susceptibility-guided vs. empiric retreatment of Heli-cobacter pylori infection after treatment failure. Dig Dis Sci 2006;51:2316-2321
18. Sherif M, Mohran Z, Fathy H, Rockabrand DM, Rozmajzl PJ, Frenck RW. Universal high-level primary met-ronidazole resistance in Helicobacter pylori isolated from children in Egypt. J Clin Microbiol 2004;42:4832-4834 (Pubitemid 39362416)
19. Falsafi T, Mobasheri F, Nariman F, Najafi M. Susceptibilities to different antibiotics of Helicobacter pylori strains isolated from patients at the pediatric medical center of Tehran, Iran. J Clin Microbiol 2004;42:387-389 (Pubitemid 38082753)
20. Boyanova L, Mentis A, Gubina M, Rozynek E, Gosciniak G, Kalenic S, et al. The status of antimicrobial resistance of Helicobacter pylori in eastern Europe. Clin Microbiol Infect 2002;8:388-396 (Pubitemid 34993815)
21. Bradley JS, Arguedas A, Blumer JL, Saez-Llorens X, Melkote R, Noel GJ. Comparative study of levofloxacin in the treatment of children with community-acquired pneumonia. Pediatr Infect Dis J 2007;26:868-878 (Pubitemid 47494158)
22. Noel GJ, Bradley JS, Kauffman RE, Duffy CM, Gerbino PG, Arquedas A, et al. Comparative safety profile of levofloxacin in 2523 children with a focus on four specific musculoskeletal disorders. Pediatr Infect Dis J 2007;26:879-891
23. Rothenbacher D, Winkler M, Gonser T, Adler G, Brenner H. Role of infected parents in transmission of helicobacter pylori to their children. Pediatr Infect Dis J 2002;21:674-679 (Pubitemid 34761451)
24. Toltzis P, Dul M, Blumer J. Change in pneumococcal susceptibility to azithromycin during treatment for acute otitis media. Pediatr Infect Dis J 2007;26:647-649 (Pubitemid 47014171)
25. Barkai G, Greenberg D, Givon-Lavi N, Dreifuss E, Vardy D, Dagan R. Community prescribing and resistant Streptococcus pneumoniae. Emerg Infect Dis 2005;11:829-837 (Pubitemid 40720842)
26. Raymond J, Burucoa C, Pietrini O, Bergeret M, Decoster A, Wann A, et al. Clarithromycin resistance in Helicobacter pylori strains isolated from French children: prevalence of the different mutations and coexistence of clones harboring two different mutations in the same biopsy. Helicobacter 2007;12:157-163 (Pubitemid 46272570)
27. Yilmaz O, Demiray E, Tumer S, Altungoz O, Yorukoglu K, Soyturk M, et al. Detection of Helicobacter pylori and determination of clarithromycin susceptibility using formalin-fixed, paraffin-embedded gastric biopsy specimens by fluorescence in situ hybridization. Helicobacter 2007;12:136-141 (Pubitemid 46272567)
28. Lopes AI, Oleastro M, Palha A, Fernandes A, Monteiro L. Antibiotic-resistant Helicobacter pylori strains in Portuguese children. Pediatr Infect Dis J 2005;24:404-409 (Pubitemid 40664234)